Rocket Lab’s $266 Million Win Caps a Week of Government Expansion — But Wall Street Remains Unmoved
Published on 07/24/2026 at 08:21 | Redaktion boerse-global.de
The US Space Force has dramatically widened the aperture for national security launches, and Rocket Lab is one of the beneficiaries — yet the stock continues to trade as if the news barely registered. On July 17, the Space Force raised the ceiling on its “National Security Space Launch” program’s Lane 1 contract from $5.6 billion to $17 billion, a near-tripling of the available pool. Seven companies now sit inside that expanded framework, including Rocket Lab, which joined the roster through a backfill process after initially being passed over in 2024.
Just one business day later, on July 20, the US Air Force awarded Rocket Lab a firm-fixed-price contract worth $266 million for twelve suborbital Electron launches from the Pacific Spaceport in Alaska, with work running through December 2028 and an option for six additional missions. That award builds on a separate $190 million Air Force contract already in hand this year. The stock ticked higher on July 22 when the news broke, but the move was modest — a far cry from the kind of reaction that might accompany a company landing two major government expansions in the span of a week.
The Neutron Hurdle
The reason for the market’s muted response is straightforward: the Lane 1 expansion unlocks a much larger opportunity, but it doesn’t put cash in the bank. Actual mission assignments come through individual task orders, and to win the most lucrative ones, Rocket Lab needs its in-development Neutron rocket to fly. The reusable medium-lift vehicle, designed to carry up to 13,000 kilograms to low Earth orbit, has suffered repeated schedule slips. A first-stage fuel tank ruptured during a pressure test in January, traced to a manufacturing defect in a hand-built component. The company has since replaced that tank with a version produced through automated manufacturing and has applied to the FAA for a launch window running from July 1 through December 31, 2026.
CEO Peter Beck has been characteristically cautious, stating that the rocket will launch only when it is ready. The company’s Archimedes engine recently generated roughly 1.5 million pounds of thrust in testing, and the AVac vacuum engine for the second stage has also been fired. But until Neutron actually reaches orbit, Rocket Lab remains effectively locked out of the largest and most complex Lane 1 missions. Of the seven companies in the expanded pool, only SpaceX, United Launch Alliance, and Blue Origin have successfully launched rockets; Blue Origin’s New Glenn is still working through certification for the more demanding Lane 2 tier.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
A Record Backlog, but a Bruised Stock
The gap between Rocket Lab’s operational achievements and its stock price has rarely been wider. The company’s backlog has swelled to $2.2 billion, anchored by a December 2025 award from the US Space Development Agency worth $816 million for 18 satellites tracking ballistic and hypersonic threats — the largest single contract in company history — plus a separate $515 million satellite order. Revenue in fiscal 2025 reached $601.8 million, up 38 percent year-over-year, and the first quarter of fiscal 2026 saw sales jump 63.5 percent to $200.3 million while the net loss narrowed 25.7 percent to $45 million.
Yet the stock closed recently at $69.99, roughly 54 percent below its 52-week high of $151 set on May 27. The 14-day relative strength index sits at 33.5, deep in oversold territory. The sell-off accelerated in June after Rocket Lab announced its $8 billion acquisition of Iridium Communications, a deal designed to transform the company from a pure launch provider into an end-to-end space operator with access to satellite operations and L-band spectrum. CEO Peter Beck sold $465 million worth of stock around the same time, and the shares slid from above $100 to below $70.
Analysts Split as Earnings Approach
The analyst community is divided on what comes next. Piper Sandler initiated coverage with a neutral rating and a $83 price target, while the broader consensus points to targets between $108 and $120, with a majority of analysts maintaining buy ratings. The stock now trades roughly 10.5 percent below its 200-day moving average, underscoring the persistent downward pressure of recent weeks — though on a twelve-month basis it still shows a gain of about 45 percent, suggesting the pullback has corrected an earlier, much sharper rally.
Rocket Lab USA at a turning point? This analysis reveals what investors need to know now.
The next major catalyst arrives on August 10, 2026, when Rocket Lab reports second-quarter results after US markets close. Investors will be watching for updates on Neutron’s timeline, the integration of Iridium, and whether the company’s expanding government pipeline is beginning to translate into cash flow. The Space Force’s Lane 1 expansion, the $266 million HASTE contract, and two NASA awards won in late June under the VADR program — the PolSIR and TSIS-2 missions, worth up to $300 million over a decade — all point to deepening demand from Washington. But for the stock to recover, the market needs proof that Neutron can fly, and that the Iridium deal will deliver on its strategic promise without further diluting shareholder value.
Ad
Rocket Lab USA Stock: New Analysis - 24 July
Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
